Accelerating discoveries in the proteome and genome with MALDI TOF MS

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.1, Iss.3, 2000-08, pp. : 359-366

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Proteomic Profiling of Invasive Ductal Carcinoma (IDC) using Magnetic Beads‐based Serum Fractionation and MALDI‐TOF MS

Journal Of Clinical Laboratory Analysis (Electronic), Vol. 29, Iss. 4, 2015-07 ,pp. : 321-327

John Wiley & Sons Inc

Access to resources Recommend Favorite

MALDI-TOF mass spectrometry-based SNP genotyping

By Pusch Wolfgang Wurmbach Jan-Henner Thiele Herbert Kostrzewa Markus

Pharmacogenomics, Vol. 3, Iss. 4, 2002-07 ,pp. : 537-548

Future Medicine

Access to resources Recommend Favorite

Application of MALDI-TOF Mass Spectrometry in Screening and Diagnostic Research

Current Pharmaceutical Design, Vol. 11, Iss. 20, 2005-08 ,pp. : 2577-2591

Bentham Science Publishers

Access to resources Recommend Favorite

Functional Genome and Proteome Analyses of Cutaneous Autoimmune Diseases

Current Pharmaceutical Design, Vol. 12, Iss. 29, 2006-10 ,pp. : 3787-3798

Bentham Science Publishers

Access to resources Recommend Favorite

Towards microfluidic technology-based MALDI-MS platforms for drug discovery: a review

By Winkle Richard F Nagy Judit M Cass Anthony EG Sharma Sanjiv

Expert Opinion on Drug Discovery, Vol. 3, Iss. 11, 2008-11 ,pp. : 1281-1292

Informa Healthcare

Access to resources Recommend Favorite